Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Covid after Vaccine; Covid after Vaccine; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A male patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization Series Completed; Manufacturer unknown), for Covid-19 Immunization. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Covid after Vaccine". Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: the reporter (patient's wife) stated they both had covid and took Paxlovid. Reporter said she was having severe hip pain and her, and her husband had all their covid shots (Pfizer Shots) and she does not understand why she still got covid. They never had Covid, they took all the shots and everything they needed to do. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. Follow-up (03Apr2025): Follow-up attempts are completed. Batch/lot number is not provided, and it cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500039765 Same reporter/product/event, different patient;